Identification and Evaluation of Dibasic Piperidines as Cell Wall Inhibitors against Mycobacterium tuberculosis.
Saved in:
| Title: | Identification and Evaluation of Dibasic Piperidines as Cell Wall Inhibitors against Mycobacterium tuberculosis. |
|---|---|
| Authors: | Naylor C; Drug Discovery Unit, Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K., Prosser G; Drug Discovery Unit, Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K., Bayliss T; Drug Discovery Unit, Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K., Berle LF; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, 9000 Rockville Pike, Bethesda, Maryland 20892, United States., Wallach JB; Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York 10065, United States., Kim H; Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York 10065, United States., Aguilera Olvera R; Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York 10065, United States., Thompson S; Drug Discovery Unit, Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K., Ioerger TR; Department of Computer Science and Engineering, Texas A&M University, College Station, Texas 77843, United States., Simpson L; Drug Discovery Unit, Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K., Casanueva R; Global Health Medicines R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain., Guijarro-Lopez L; Global Health Medicines R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain., Read KD; Drug Discovery Unit, Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K., Wyatt PG; Drug Discovery Unit, Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K., Schnappinger D; Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York 10065, United States., Barry CE; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, 9000 Rockville Pike, Bethesda, Maryland 20892, United States., Green SR; Drug Discovery Unit, Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K., Boshoff HIM; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, 9000 Rockville Pike, Bethesda, Maryland 20892, United States., Cleghorn LAT; Drug Discovery Unit, Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K. |
| Source: | ACS infectious diseases [ACS Infect Dis] 2026 Jun 12; Vol. 12 (6), pp. 2004-2014. Date of Electronic Publication: 2026 May 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: ACS Publications Country of Publication: United States NLM ID: 101654580 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2373-8227 (Electronic) Linking ISSN: 23738227 NLM ISO Abbreviation: ACS Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42135210 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Identification and Evaluation of Dibasic Piperidines as Cell Wall Inhibitors against Mycobacterium tuberculosis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Naylor+C%22">Naylor C</searchLink>; Drug Discovery Unit, Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.<br /><searchLink fieldCode="AU" term="%22Prosser+G%22">Prosser G</searchLink>; Drug Discovery Unit, Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.<br /><searchLink fieldCode="AU" term="%22Bayliss+T%22">Bayliss T</searchLink>; Drug Discovery Unit, Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.<br /><searchLink fieldCode="AU" term="%22Berle+LF%22">Berle LF</searchLink>; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, 9000 Rockville Pike, Bethesda, Maryland 20892, United States.<br /><searchLink fieldCode="AU" term="%22Wallach+JB%22">Wallach JB</searchLink>; Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York 10065, United States.<br /><searchLink fieldCode="AU" term="%22Kim+H%22">Kim H</searchLink>; Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York 10065, United States.<br /><searchLink fieldCode="AU" term="%22Aguilera+Olvera+R%22">Aguilera Olvera R</searchLink>; Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York 10065, United States.<br /><searchLink fieldCode="AU" term="%22Thompson+S%22">Thompson S</searchLink>; Drug Discovery Unit, Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.<br /><searchLink fieldCode="AU" term="%22Ioerger+TR%22">Ioerger TR</searchLink>; Department of Computer Science and Engineering, Texas A&M University, College Station, Texas 77843, United States.<br /><searchLink fieldCode="AU" term="%22Simpson+L%22">Simpson L</searchLink>; Drug Discovery Unit, Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.<br /><searchLink fieldCode="AU" term="%22Casanueva+R%22">Casanueva R</searchLink>; Global Health Medicines R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Guijarro-Lopez+L%22">Guijarro-Lopez L</searchLink>; Global Health Medicines R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Read+KD%22">Read KD</searchLink>; Drug Discovery Unit, Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.<br /><searchLink fieldCode="AU" term="%22Wyatt+PG%22">Wyatt PG</searchLink>; Drug Discovery Unit, Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.<br /><searchLink fieldCode="AU" term="%22Schnappinger+D%22">Schnappinger D</searchLink>; Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York 10065, United States.<br /><searchLink fieldCode="AU" term="%22Barry+CE%22">Barry CE</searchLink>; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, 9000 Rockville Pike, Bethesda, Maryland 20892, United States.<br /><searchLink fieldCode="AU" term="%22Green+SR%22">Green SR</searchLink>; Drug Discovery Unit, Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.<br /><searchLink fieldCode="AU" term="%22Boshoff+HIM%22">Boshoff HIM</searchLink>; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, 9000 Rockville Pike, Bethesda, Maryland 20892, United States.<br /><searchLink fieldCode="AU" term="%22Cleghorn+LAT%22">Cleghorn LAT</searchLink>; Drug Discovery Unit, Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101654580%22">ACS infectious diseases</searchLink> [ACS Infect Dis] 2026 Jun 12; Vol. 12 (6), pp. 2004-2014. <i>Date of Electronic Publication: </i>2026 May 14. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22ACS+Publications%22">ACS Publications </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101654580 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2373-8227 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223738227%22">23738227 </searchLink><i>NLM ISO Abbreviation: </i>ACS Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42135210 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1021/acsinfecdis.6c00123 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2004 Titles: – TitleFull: Identification and Evaluation of Dibasic Piperidines as Cell Wall Inhibitors against Mycobacterium tuberculosis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Naylor C – PersonEntity: Name: NameFull: Prosser G – PersonEntity: Name: NameFull: Bayliss T – PersonEntity: Name: NameFull: Berle LF – PersonEntity: Name: NameFull: Wallach JB – PersonEntity: Name: NameFull: Kim H – PersonEntity: Name: NameFull: Aguilera Olvera R – PersonEntity: Name: NameFull: Thompson S – PersonEntity: Name: NameFull: Ioerger TR – PersonEntity: Name: NameFull: Simpson L – PersonEntity: Name: NameFull: Casanueva R – PersonEntity: Name: NameFull: Guijarro-Lopez L – PersonEntity: Name: NameFull: Read KD – PersonEntity: Name: NameFull: Wyatt PG – PersonEntity: Name: NameFull: Schnappinger D – PersonEntity: Name: NameFull: Barry CE – PersonEntity: Name: NameFull: Green SR – PersonEntity: Name: NameFull: Boshoff HIM – PersonEntity: Name: NameFull: Cleghorn LAT IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 06 Text: 2026 Jun 12 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2373-8227 Numbering: – Type: volume Value: 12 – Type: issue Value: 6 Titles: – TitleFull: ACS infectious diseases Type: main |
| ResultId | 1 |